Sweden · Investor

Healthcap IX Advisor AB

Last cheque observed Dec 2012. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietInvestment firm

Series CSeries AVenture

Cheques on record
0%of best year0cheques in 12 months, 24 on record
Since the last cheque5047days00hrs00min00sec
Median round$20MRounds led0 of 24Sole investor1 roundsExits4 from the portfolioMostly inUnited States, 46%
Pitch Healthcap IX Advisor AB

Healthcap IX Advisor AB highlights

  1. 01

    24 rounds on record

  2. 02

    Mostly Series C and Series A: 52% of its rounds

  3. 03

    Sole investor in 1 rounds, median $5.5M

  4. 04

    4 exits from the portfolio

What they do

SEC Form ADV: exempt reporting adviserFrom their own website
Type
Investment firm (from a list, unverified)
Cheque size
Not stated
Based in
Stockholm, Sweden
Cold pitches
Not stated

The record

Every round we can evidence, newest first24 appearances

  1. 2012

    2 rounds

  2. Dec
    Ultragenyx PharmaceuticalGrowth · US · globenewswire.com$75MWith 6 others
  3. Jun
    BONESUPPORTSE · finsmes.com$10.0MWith 2 others
  4. 2011

    4 rounds

  5. Jul
    SpineVisionVenture · FR · finsmes.com$5.0MWith 3 others
  6. Jun
    BONESUPPORTVenture · SE · finsmes.com$19MWith 1 other
  7. Jun
    Ultragenyx PharmaceuticalSeries A · US · finsmes.com$45MWith 4 others
  8. Jan
    NexstimVenture · FI · tmcnet.com$15MWith 5 others
  9. 2010

    6 rounds

  10. Sept
    CardozSeries A · SE · finsmes.com$18MWith 3 others
  11. Jul
    Cerenis TherapeuticsSeries C · FR · cerenis.com$52MWith 6 others
  12. Jun
    FerroKin BiosciencesSeries B · US · fiercebiotech.com$12MWith 4 others
  13. Apr
    Oncos TherapeuticsSeries C · FI · onbiovc.com$5.5MSole investor
  14. Mar
    Immune Targeting SystemsSeries A · GB · onbiovc.com$13MWith 3 others
  15. Mar
    PulmonxSeries C · US · onbiovc.com$32MWith 6 others
  16. 2009

    2 rounds

  17. Sept
    BeneChillSeries C · US · onbiovc.com$14MWith 2 others
  18. Jun
    LumavitaSeries A · CH · onbiovc.com$5.5MWith 1 other
  19. 2007

    2 rounds

  20. Oct
    TengionSeries C · US · tengion.com$33MWith 8 others
  21. Jun
    OxTheraSE · oxthera.com$22MWith 3 others
  22. 2006

    3 rounds

  23. Nov
    BONESUPPORTSE · bulletin.sciencebusiness.net$20MWith 5 others
  24. Sept
    Resistentia PharmaceuticalsSeries C · SE$14MWith 4 others
  25. Jun
    TengionSeries B · US · tengion.com$50MWith 6 others
  26. 2005

    4 rounds

  27. Nov
    PTC TherapeuticsGrowth · US · ptct.client.shareholder.com$27MWith 10 others
  28. Aug
    TengionSeries A · US · phx.corporate-ir.net$39MWith 3 others
  29. Jul
    OxTheraVenture · SE · oxthera.com$21MWith 1 other
  30. Feb
    Five Prime TherapeuticsVenture · US · fiveprime.com$45MWith 9 others
  31. 2004

    1 round

  32. Jun
    ChemoCentryxSeries B · US · chemocentryx.com$33MWith 4 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

$3.4Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
Legal name
Healthcap IX Advisor AB
SEC number
CRD 330436

Exits from the portfolio

Companies it backed that were later bought or listed4 in all

Immune Targeting SystemsBought by VaxinUndisclosedFeb 2015
Five Prime TherapeuticsListedUndisclosedJul 2013
PTC TherapeuticsListed$125MJun 2013
TengionListedUndisclosedApr 2010

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Healthcap IX Advisor AB. A count of rooms they were both in, not a relationship either has claimed.

IndustrifondenVC firm5rounds togetherJohnson & Johnson Development Corporation (JJDC)VC firm3rounds togetherL Capital PartnersVC firm3rounds togetherOak Investment PartnersPrivate equity3rounds togetherAlta PartnersVC firm2rounds togetherBain CapitalPrivate equity2rounds togetherF-Prime CapitalVC firm2rounds togetherFidelity BiosciencesInvestment firm2rounds togetherHBM BioVenturesGrowth equity2rounds togetherInnovationsKapitalInvestment firm2rounds togetherKleiner Perkins Caufield & ByersVC firm2rounds togetherLundbeckfond VenturesVC firm2rounds together

Quick answers about Healthcap IX Advisor AB

What does Healthcap IX Advisor AB invest in?

Healthcap IX Advisor AB invests most often at Series C and Series A (52% of the rounds on record).

How active is Healthcap IX Advisor AB?

24 investments on record, 0 of them in the last 12 months. The most recent was in Dec 2012.

How big are Healthcap IX Advisor AB's cheques?

The median round it joins is $20M.

Does Healthcap IX Advisor AB lead rounds?

Rarely, if at all: none of its 24 investments on record names it as the lead.

Where does Healthcap IX Advisor AB invest?

Most of the companies it backs are in the United States (46%), Sweden (29%) and France (8%).

Is Healthcap IX Advisor AB investing now?

No investments in the last 12 months; the latest was in Dec 2012.

Who does Healthcap IX Advisor AB invest alongside?

Most often Industrifonden (5 rounds together), Johnson & Johnson Development Corporation (JJDC) (3 rounds together) and L Capital Partners (3 rounds together).

What kind of investor is Healthcap IX Advisor AB?

Healthcap IX Advisor AB is an investment firm based in Stockholm, Sweden.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it